Global Immune Cell Therapy Market Growth (Status and Outlook) 2022-2028

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Immune Cell Therapy Market Size 2022-2028
  • 2.1.2 Immune Cell Therapy Market Size CAGR by Region
• 2.2 Immune Cell Therapy Segment by Type
  • 2.2.1 T Cell Therapy
  • 2.2.2 Natural Killer (NK) Cell Therapy
  • 2.2.3 Other
• 2.3 Immune Cell Therapy Market Size by Type
  • 2.3.1 Global Immune Cell Therapy Market Size Market Share by Type (2022-2028)
  • 2.3.2 Global Immune Cell Therapy Market Size Growth Rate by Type (2022-2028)
• 2.4 Immune Cell Therapy Segment by Application
  • 2.4.1 Stomach Cancer
  • 2.4.2 Lung Cancer
  • 2.4.3 Colorectal Cancer
  • 2.4.4 Esophageal Cancer
  • 2.4.5 Pancreatic Cancer
  • 2.4.6 Other
• 2.5 Immune Cell Therapy Market Size by Application
  • 2.5.1 Global Immune Cell Therapy Market Size Market Share by Application (2022-2028)
  • 2.5.2 Global Immune Cell Therapy Market Size Growth Rate by Application (2022-2028)

3 Immune Cell Therapy Key Players

• 3.1 Date of Key Players Enter into Immune Cell Therapy
• 3.2 Key Players Immune Cell Therapy Product Offered
• 3.3 Key Players Immune Cell Therapy Funding/Investment Analysis
• 3.4 Funding/Investment
  • 3.4.1 Funding/Investment by Regions
  • 3.4.2 Funding/Investment by End-Industry
• 3.5 Key Players Immune Cell Therapy Valuation & Market Capitalization
• 3.6 Key Players Mergers & Acquisitions, Expansion Plans
• 3.7 Market Ranking
• 3.8 New Product/Technology Launches
• 3.9 Partnerships, Agreements, and Collaborations
• 3.10 Mergers and Acquisitions

4 Immune Cell Therapy by Regions

• 4.1 Immune Cell Therapy Market Size by Regions (2022-2028)
• 4.2 United States Immune Cell Therapy Market Size Growth (2022-2028)
• 4.3 China Immune Cell Therapy Market Size Growth (2022-2028)
• 4.4 Europe Immune Cell Therapy Market Size Growth (2022-2028)
• 4.5 Rest of World Immune Cell Therapy Market Size Growth (2022-2028)

5 United States

• 5.1 United States Immune Cell Therapy Market Size by Type (2022-2028)
• 5.2 United States Immune Cell Therapy Market Size by Application (2022-2028)

6 China

• 6.1 China Immune Cell Therapy Market Size by Type (2022-2028)
• 6.2 China Immune Cell Therapy Market Size by Application (2022-2028)

7 Europe

• 7.1 Europe Immune Cell Therapy Market Size by Type (2022-2028)
• 7.2 Europe Immune Cell Therapy Market Size by Application (2022-2028)

8 Rest of World

• 8.1 Rest of World Immune Cell Therapy Market Size by Type (2022-2028)
• 8.2 Rest of World Immune Cell Therapy Market Size by Application (2022-2028)
• 8.3 Japan
• 8.4 South Korea
• 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers & Growth Opportunities
• 9.2 Market Challenges & Risks
• 9.3 Industry Trends

10 Key Investors in Immune Cell Therapy

• 10.1 Company A
  • 10.1.1 Company A Company Details
  • 10.1.2 Company Description
  • 10.1.3 Companies Invested by Company A
  • 10.1.4 Company A Key Development and Market Layout
• 10.2 Company B
  • 10.2.1 Company B Company Details
  • 10.2.2 Company Description
  • 10.2.3 Companies Invested by Company B
  • 10.2.4 Company B Key Development and Market Layout
• 10.3 Company C
  • 10.3.1 Company C Company Details
  • 10.3.2 Company Description
  • 10.3.3 Companies Invested by Company C
  • 10.3.4 Company C Key Development and Market Layout
• 10.4 Company D
• 10.5 ……

11 Key Players Analysis

• 11.1 Adaptimmune
  • 11.1.1 Adaptimmune Company Details
  • 11.1.2 Adaptimmune Immune Cell Therapy Product Offered
  • 11.1.3 Adaptimmune Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.1.4 Adaptimmune Main Business Overview
  • 11.1.5 Adaptimmune News
• 11.2 Altor Bioscience Corporation
  • 11.2.1 Altor Bioscience Corporation Company Details
  • 11.2.2 Altor Bioscience Corporation Immune Cell Therapy Product Offered
  • 11.2.3 Altor Bioscience Corporation Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.2.4 Altor Bioscience Corporation Main Business Overview
  • 11.2.5 Altor Bioscience Corporation News
• 11.3 Cellectis
  • 11.3.1 Cellectis Company Details
  • 11.3.2 Cellectis Immune Cell Therapy Product Offered
  • 11.3.3 Cellectis Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.3.4 Cellectis Main Business Overview
  • 11.3.5 Cellectis News
• 11.4 Juno Therapeutics
  • 11.4.1 Juno Therapeutics Company Details
  • 11.4.2 Juno Therapeutics Immune Cell Therapy Product Offered
  • 11.4.3 Juno Therapeutics Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.4.4 Juno Therapeutics Main Business Overview
  • 11.4.5 Juno Therapeutics News
• 11.5 Kite Pharma
  • 11.5.1 Kite Pharma Company Details
  • 11.5.2 Kite Pharma Immune Cell Therapy Product Offered
  • 11.5.3 Kite Pharma Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.5.4 Kite Pharma Main Business Overview
  • 11.5.5 Kite Pharma News
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Novartis Immune Cell Therapy Product Offered
  • 11.6.3 Novartis Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.6.4 Novartis Main Business Overview
  • 11.6.5 Novartis News
• 11.7 Takara Bio
  • 11.7.1 Takara Bio Company Details
  • 11.7.2 Takara Bio Immune Cell Therapy Product Offered
  • 11.7.3 Takara Bio Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.7.4 Takara Bio Main Business Overview
  • 11.7.5 Takara Bio News
• 11.8 Unum Therapeutics
  • 11.8.1 Unum Therapeutics Company Details
  • 11.8.2 Unum Therapeutics Immune Cell Therapy Product Offered
  • 11.8.3 Unum Therapeutics Immune Cell Therapy Market Size (2022 VS 2027)
  • 11.8.4 Unum Therapeutics Main Business Overview
  • 11.8.5 Unum Therapeutics News

12 Research Findings and Conclusion